Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-16

Clinical Trial Update: INdobufen Versus asPirin in Endovascular Unruptured Intracranial Aneurysms Treatment (INPUT) [NA]

View source ↗

Summary

A recruiting clinical trial comparing indobufen to aspirin for endovascular treatment of unruptured intracranial aneurysms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)
  • Indobufen (indobufen)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Unruptured Intracranial Aneurysm, Indobufen | NA | Status: RECRUITING